You are here
IC Directors’ Meeting Highlights — Thursday, November 29, 2018
Dr. Wolinetz provided perspectives from the international summit on gene editing in Hong Kong, and described the news and reactions following the gene-edited embryo presentation.
Dr. Tabak previewed presentations for the upcoming Advisory Committee to the Director (ACD) meeting December 13-14. The followup to the ACD Working Group for Review of the Moderate Alcohol and Cardiovascular Health Trial Report, and the preliminary recommendations from the ACD Working Group on High-Risk, High-Reward Research were both presented and discussed.
This page last reviewed on April 3, 2019